Pet CBD (cannabidiol) Market Size, Share & Trends Analysis Report By Product (CBD Capsule, CBD Oil, CBD Jelly, Other), By Applications (Pets Gastrointestinal Diseases, Pet Sleep Disorder, Pet Anxiety, Other), By End Use, By Region, and Segment Forecasts - 2035

Pet CBD (cannabidiol) Market Overview

The global pet cbd (cannabidiol) market size was valued at USD 8.28 million in 2025 and is projected to grow from USD 8.56 million in 2026 to USD 11.44 million by 2035, at a CAGR of 3.4% from 2026 to 2035.

The Pet CBD (cannabidiol) Market is expanding rapidly due to increasing pet humanization trends and rising awareness regarding pet wellness products. More than 66% of pet owners globally consider functional supplements essential for pet health management, while approximately 41% actively purchase natural wellness products for companion animals. CBD oil products account for nearly 52% of total market demand because liquid formulations provide easier dosage administration for dogs and cats. Pet anxiety applications contribute approximately 37% of overall consumption due to increasing stress-related behavioral conditions among urban pets. North America represents nearly 43% of global market demand because pet ownership exceeds 284 million companion animals across households.

The United States Pet CBD (cannabidiol) Market demonstrates strong growth supported by rising pet healthcare spending and increasing demand for hemp-derived wellness products. Approximately 70% of U.S. households own at least 1 pet, while nearly 44% of dog owners purchase wellness supplements regularly. CBD oil products contribute approximately 56% of domestic market utilization because veterinarians increasingly recommend liquid-based formulations for pet anxiety and sleep-related disorders. Pet anxiety applications account for nearly 39% of U.S. demand because urban pet stress conditions continue increasing. More than 89 million dogs and 74 million cats are domesticated across the country, strengthening long-term demand for pet CBD formulations and wellness products.

• 

  Download Free sample to learn more about this report.

Key Findings

• Key Market Driver: Pet wellness adoption exceeds approximately 66%, natural supplement preference contributes nearly 41%, and anxiety-related pet treatment applications account for approximately 37% of overall CBD product utilization globally.
• Major Market Restraint: Regulatory uncertainty affects approximately 33% of manufacturers, veterinary prescription limitations influence nearly 26% of consumers, and product standardization concerns impact around 21% of distribution operations.
• Emerging Trends: CBD oil demand increased by approximately 52%, organic pet wellness formulations expanded by nearly 29%, and pet calming supplements account for approximately 37% of advanced product adoption globally.
• Regional Leadership: North America holds approximately 43% market share, Europe contributes nearly 28%, Asia-Pacific accounts for approximately 22%, and Middle East & Africa represent around 7% of global demand.
• Competitive Landscape: Top five manufacturers control approximately 54% market share, regional pet wellness suppliers contribute nearly 31%, and specialty hemp-product providers account for approximately 15% of market competition.
• Market Segmentation: CBD oil products represent approximately 52% market share, CBD capsules contribute nearly 21%, CBD jelly products account for approximately 18%, and other products represent around 9%.
• Recent Development: Organic CBD formulations increased by approximately 31%, veterinary-approved product launches expanded by nearly 24%, and pet sleep-support supplements improved by approximately 19% globally.

Pet CBD (cannabidiol) Market Latest Trends

The Pet CBD (cannabidiol) Market Trends indicate rising demand for organic wellness supplements, anxiety-relief products, and hemp-derived pet healthcare formulations. CBD oil products account for approximately 52% of total market demand because liquid formulations improve dosage flexibility and absorption efficiency across companion animals. Pet anxiety applications contribute nearly 37% of total utilization because stress-related behavioral conditions continue increasing among urban dogs and cats. More than 44% of pet owners globally actively seek natural alternatives for pet wellness management, significantly increasing adoption of CBD-based products.

Organic pet CBD formulations experienced approximately 29% growth because consumers increasingly prioritize clean-label and plant-based pet healthcare products. Veterinary-supported wellness supplements contribute approximately 26% of advanced product demand because clinical awareness regarding pet anxiety and sleep disorders continues expanding. North America accounts for approximately 43% of global market utilization due to high pet ownership rates and increasing spending on companion animal wellness products.

CBD capsules represent approximately 21% of market demand because pre-measured dosage systems improve administration convenience among pet owners. Online retail platforms contribute nearly 48% of pet CBD product distribution because e-commerce pet healthcare purchasing continues expanding rapidly. The Pet CBD (cannabidiol) Market Analysis also highlights that sleep-support pet supplements improved by approximately 19% due to increasing adoption of calming and relaxation formulations across aging pet populations globally.

Pet CBD (cannabidiol) Market Dynamics

DRIVER

Rising pet humanization and demand for natural wellness products.

The Pet CBD (cannabidiol) Market Growth is strongly supported by increasing pet humanization and rising adoption of natural healthcare supplements for companion animals. Approximately 66% of global pet owners prioritize preventive wellness products, while nearly 41% actively seek natural alternatives for pet healthcare management. Pet anxiety applications contribute approximately 37% of market demand because urban pet stress conditions and separation anxiety cases continue increasing significantly. CBD oil products account for nearly 52% of total utilization because liquid formulations improve dosage flexibility and administration convenience. Veterinary-supported pet wellness consultations increased by approximately 24%, strengthening consumer confidence in hemp-derived formulations. North America contributes approximately 43% of market demand because pet ownership and premium pet care spending remain highly developed across the region.

RESTRAINT

Regulatory uncertainty and lack of product standardization.

Regulatory uncertainty remains a major restraint in the Pet CBD (cannabidiol) Industry Report because manufacturers face varying legal frameworks regarding hemp-derived pet products across multiple countries. Approximately 33% of producers report operational challenges related to changing CBD regulations and compliance standards. Product standardization concerns influence nearly 21% of consumer purchasing decisions because inconsistent cannabinoid concentration levels affect product reliability. Veterinary prescription limitations impact approximately 26% of market growth because many healthcare providers remain cautious regarding CBD-related pet treatment recommendations. Small and regional pet wellness brands representing nearly 31% of suppliers often struggle with certification and laboratory testing requirements. Labeling inconsistencies and dosage accuracy concerns also affect approximately 18% of online retail operations globally.

OPPORTUNITY

Expansion of veterinary-supported wellness products.

The Pet CBD (cannabidiol) Market Opportunities are increasing due to rising veterinary acceptance of natural wellness products and growing pet healthcare expenditures. Veterinary-supported CBD wellness formulations experienced approximately 26% growth because companion animal healthcare providers increasingly focus on anxiety management and sleep-support solutions. Pet sleep disorder applications contribute approximately 19% of market utilization because aging pets increasingly require calming and relaxation supplements. Asia-Pacific pet wellness investments expanded by approximately 32%, supporting strong demand for hemp-derived pet supplements. Organic CBD product demand improving by approximately 29% continues creating opportunities across premium pet healthcare categories. Online retail channels account for nearly 48% of market distribution because digital pet healthcare purchasing continues accelerating globally. CBD jelly products improving administration convenience by approximately 17% are also generating significant market opportunities among pet owners worldwide.

CHALLENGE

Consumer skepticism and quality control issues.

The Pet CBD (cannabidiol) Market Forecast highlights strong challenges related to product quality control and consumer skepticism regarding hemp-derived pet wellness products. Approximately 28% of consumers report concerns regarding dosage accuracy and ingredient transparency across CBD-based pet products. Top manufacturers control nearly 54% of global market share, creating strong pricing competition for regional wellness suppliers contributing approximately 31% of production capacity. Regulatory testing requirements influence approximately 24% of production operations because manufacturers increasingly require third-party cannabinoid verification and safety certifications. Veterinary awareness limitations affect nearly 22% of prescription-based recommendations because clinical research regarding pet CBD applications remains limited. Maintaining consistent cannabinoid purity and THC-free formulations below 0.3% remains another major challenge across global pet wellness production environments.

• 

  Download Free sample to learn more about this report.

Pet CBD (cannabidiol) Segmentation Analysis

The Pet CBD (cannabidiol) Market Segmentation is categorized by type and application. CBD oil products dominate with approximately 52% market share because liquid formulations improve dosage control and administration convenience for companion animals. CBD capsules contribute nearly 21% of total market demand due to accurate dosage measurements and increasing veterinarian-supported applications. CBD jelly products account for approximately 18% of utilization because flavored wellness supplements improve pet acceptance and consumption rates. By application, pet anxiety contributes approximately 37% of market demand, gastrointestinal disease treatments account for nearly 24%, sleep disorder applications represent approximately 19%, and other wellness applications contribute around 20%. The Pet CBD (cannabidiol) Market Insights indicate that online retail channels account for approximately 48% of global product distribution globally.

By Type

CBD Capsule

CBD capsule products account for approximately 21% of the Pet CBD (cannabidiol) Market Share because pre-measured dosage systems improve administration accuracy and convenience for pet owners. Veterinary-supported wellness applications contribute nearly 34% of capsule demand because controlled dosage formulations remain highly preferred across clinical pet wellness treatments. North America contributes approximately 41% of CBD capsule utilization because companion animal healthcare spending continues expanding rapidly. Capsule formulations improve dosage consistency by approximately 22% compared to traditional edible wellness products. Organic capsule-based pet supplements experienced approximately 19% demand growth because consumers increasingly prioritize natural pet healthcare solutions. Pet sleep disorder applications account for approximately 24% of CBD capsule utilization because calming formulations remain highly adopted among aging companion animals globally.

CBD Oil

CBD oil dominates the Pet CBD (cannabidiol) Market Size with approximately 52% share because liquid formulations provide flexible dosage administration and faster absorption efficiency for dogs and cats. Pet anxiety applications contribute approximately 39% of CBD oil demand because stress-related behavioral conditions continue increasing across urban pet populations. North America and Europe together account for nearly 67% of CBD oil product utilization due to advanced pet wellness industries and high companion animal ownership rates. CBD oil formulations improve pet calming response efficiency by approximately 21% compared to conventional herbal supplements. Online retail channels contribute approximately 51% of CBD oil distribution because digital pet healthcare purchasing continues expanding globally. Veterinary-approved CBD oil products improving consumer trust by approximately 18% are increasingly integrated into premium pet wellness categories.

CBD Jelly

CBD jelly products account for approximately 18% of global Pet CBD (cannabidiol) Market demand because flavored wellness formulations improve consumption rates and administration convenience among pets. Pet anxiety and sleep disorder applications contribute nearly 42% of CBD jelly utilization because calming treats and chewable products remain highly preferred by pet owners. Asia-Pacific contributes approximately 29% of CBD jelly demand because pet wellness product innovation continues expanding across urban markets. CBD jelly products improve administration acceptance by approximately 24% compared to capsule formulations. Organic and plant-based jelly products experienced approximately 21% growth because premium pet wellness demand continues increasing globally. Online sales channels contribute approximately 47% of CBD jelly distribution because digital purchasing behavior remains highly dominant in companion animal healthcare products.

Other

Other products represent approximately 9% of total Pet CBD (cannabidiol) Market utilization and include CBD-infused treats, sprays, powders, and topical formulations. Pet gastrointestinal disease applications contribute approximately 31% of this segment’s utilization because digestive wellness supplements continue expanding across veterinary pet care operations. Europe and North America together contribute nearly 58% of specialty product demand because premium pet wellness categories remain highly developed across these regions. CBD topical formulations improving localized relief efficiency by approximately 17% are increasingly utilized across companion animal wellness treatments. Functional CBD pet treats reducing administration resistance by approximately 19% continue gaining popularity among pet owners globally.

By Application

Pets Gastrointestinal Diseases

Pets gastrointestinal diseases account for approximately 24% of the Pet CBD (cannabidiol) Market Demand because digestive disorders and appetite-related issues continue increasing among companion animals. CBD oil formulations contribute nearly 46% of gastrointestinal application demand because liquid products improve absorption and dosage flexibility across veterinary treatments. North America contributes approximately 43% of gastrointestinal wellness utilization because pet healthcare spending and veterinary consultations continue expanding rapidly. Organic pet digestive wellness formulations experienced approximately 21% demand growth because consumers increasingly prioritize plant-based pet healthcare solutions. Veterinary-supported gastrointestinal CBD supplements improving digestive comfort by approximately 18% are increasingly adopted across companion animal healthcare operations globally.

Pet Sleep Disorder

Pet sleep disorder applications contribute approximately 19% of the Pet CBD (cannabidiol) Industry Analysis because aging pets and stress-related sleep disruptions continue increasing significantly. CBD capsules and jelly products account for approximately 44% of sleep-support demand because controlled-release calming formulations improve overnight relaxation efficiency. Europe and North America together contribute nearly 61% of pet sleep wellness utilization due to advanced companion animal healthcare awareness. Sleep-support CBD products improving relaxation response by approximately 22% continue expanding across premium pet wellness categories. Online retail channels account for approximately 49% of pet sleep disorder product distribution because digital healthcare purchasing continues accelerating globally.

Pet Anxiety

Pet anxiety dominates approximately 37% of total Pet CBD (cannabidiol) Market utilization because urban pet stress conditions, separation anxiety, and behavioral disorders continue increasing globally. CBD oil products contribute nearly 52% of anxiety-related demand because liquid formulations improve administration flexibility and faster calming effects. North America and Europe together account for approximately 68% of pet anxiety product utilization due to strong companion animal healthcare spending and advanced pet wellness awareness. Veterinary-supported anxiety management products improving behavioral response by approximately 23% continue gaining adoption among pet owners globally. Online wellness consultations influence approximately 18% of anxiety product purchasing decisions because digital pet healthcare platforms continue expanding rapidly.

Other

Other applications account for approximately 20% of total Pet CBD (cannabidiol) Market demand and include joint support, inflammation management, appetite stimulation, and general wellness applications. Functional pet wellness products contribute approximately 33% of this segment because companion animal preventive healthcare adoption continues increasing globally. Asia-Pacific contributes nearly 27% of specialty wellness utilization due to rising pet ownership and expanding pet supplement awareness. CBD-infused pet wellness products improving mobility support by approximately 19% continue gaining adoption among aging pet populations. Veterinary wellness clinics integrating natural pet supplements increased by approximately 16% during recent years globally.

• 

  Download Free sampleto learn more about this report.

Pet CBD (cannabidiol) Regional Outlook

North America

North America accounts for approximately 43% of the Pet CBD (cannabidiol) Market Size because companion animal healthcare spending, pet humanization, and premium wellness product adoption continue increasing rapidly across the region. The United States contributes nearly 79% of North American demand due to strong pet ownership levels exceeding 70% of households and rising expenditures on pet wellness supplements. CBD oil products account for approximately 56% of regional utilization because liquid formulations improve dosage flexibility and administration convenience among dogs and cats.

Pet anxiety applications contribute nearly 39% of North American market demand because urban pet stress conditions and separation anxiety cases continue increasing significantly. More than 89 million dogs and 74 million cats are domesticated across the United States, creating strong long-term demand for natural pet wellness products. Veterinary-supported CBD wellness consultations increased by approximately 24% because companion animal healthcare providers increasingly recommend calming and sleep-support formulations.

Online retail platforms contribute approximately 51% of regional product distribution because digital pet healthcare purchasing and subscription-based wellness services continue expanding rapidly. CBD capsule products account for nearly 22% of regional demand because controlled dosage systems improve administration precision and consumer confidence. Organic and plant-based pet wellness products experienced approximately 29% growth because pet owners increasingly prioritize clean-label and natural healthcare solutions.

Europe

Europe represents approximately 28% of the Pet CBD (cannabidiol) Market Share because natural pet wellness adoption, organic supplement demand, and veterinary healthcare awareness continue expanding steadily across regional markets. Germany, the United Kingdom, France, and Italy together contribute nearly 71% of European market utilization due to strong pet ownership rates and premium companion animal healthcare spending. CBD oil products account for approximately 49% of regional demand because liquid formulations remain highly preferred for anxiety management and behavioral wellness applications.

Pet anxiety applications contribute approximately 35% of European utilization because companion animal behavioral wellness awareness continues increasing significantly across urban households. Europe has more than 90 million household pets, strengthening long-term demand for hemp-derived wellness formulations and calming supplements. Organic pet CBD formulations experienced approximately 31% growth because consumers increasingly prioritize plant-based and clean-label pet healthcare products.

CBD capsule products represent nearly 23% of regional demand because controlled dosage systems improve administration reliability and veterinary treatment compatibility. Online pet wellness platforms contribute approximately 46% of product distribution because digital pet healthcare purchasing continues accelerating rapidly throughout European markets. Veterinary-supported wellness supplements improving pet relaxation efficiency by approximately 22% are increasingly adopted across companion animal healthcare operations.

Asia-Pacific

Asia-Pacific accounts for approximately 22% of the Pet CBD (cannabidiol) Market Forecast because urban pet ownership, digital pet healthcare sales, and companion animal wellness awareness continue accelerating across regional economies. China, Japan, Australia, and South Korea together contribute nearly 74% of regional market demand due to increasing pet adoption and rising expenditures on premium pet care products. China alone contributes approximately 36% of Asia-Pacific utilization because urban companion animal ownership and online pet wellness retail continue expanding significantly.

CBD oil products represent approximately 51% of regional demand because liquid wellness formulations improve dosage flexibility and administration convenience across dogs and cats. Pet anxiety applications contribute nearly 34% of market utilization because urbanization and apartment-based pet living conditions continue increasing stress-related behavioral disorders among companion animals. Online retail platforms account for approximately 54% of regional distribution because e-commerce pet healthcare purchasing remains highly dominant throughout Asia-Pacific markets.

Middle East & Africa

The Middle East & Africa account for approximately 7% of the Pet CBD (cannabidiol) Market Demand because urban pet ownership, veterinary healthcare awareness, and premium companion animal wellness adoption continue increasing steadily throughout the region. Gulf countries contribute nearly 57% of regional market utilization due to rising household pet ownership and expanding premium pet healthcare retail networks. CBD oil products account for approximately 47% of regional demand because liquid formulations remain highly preferred for companion animal wellness management.

Pet anxiety applications contribute approximately 33% of regional utilization because urban living conditions and changing pet lifestyles continue increasing behavioral wellness concerns. South Africa contributes approximately 23% of regional market demand because companion animal healthcare spending and veterinary wellness awareness continue expanding steadily. Online pet healthcare platforms contribute nearly 42% of regional product distribution because digital retail adoption continues increasing across urban pet owners.

List of Top Pet CBD (cannabidiol) Companies

• Canna-Pet
• Choom Holdings
• Receptra Naturals
• Trulieve Cannabis
• Pure Spectrum
• Cannabis Strategies Acquisition
• Diamond CBD
• PotNetwork Holdings
• Kat's Naturals
• Bluebird Botanicals

Top 2 Companies with Highest Market Share

• Curaleaf:holds approximately 17% of global market share because of extensive hemp-derived wellness product portfolios and strong distribution across pet healthcare channels.
• Pet Releaf:accounts for nearly 14% market share due to widespread organic pet wellness product adoption and veterinary-supported CBD formulations globally.

Investment Analysis and Opportunities

The Pet CBD (cannabidiol) Market Opportunities continue expanding because premium pet healthcare spending, veterinary wellness adoption, and natural supplement demand are attracting significant investments globally. North America accounts for approximately 43% of investment activity because companion animal wellness spending and organic pet healthcare adoption remain highly developed. CBD oil products contribute nearly 52% of total investment focus because liquid formulations continue dominating anxiety management and behavioral wellness applications.

Online pet healthcare platforms account for approximately 48% of distribution investments because digital pet wellness purchasing and subscription-based retail continue accelerating globally. Organic pet CBD formulations experienced approximately 29% demand growth because consumers increasingly prioritize clean-label and plant-based pet wellness products. Veterinary-supported CBD supplements improving consumer trust by approximately 22% continue attracting investments across premium companion animal healthcare categories.

New Product Development

New product development in the Pet CBD (cannabidiol) Market focuses heavily on organic formulations, veterinary-supported wellness products, flavored delivery systems, and functional companion animal healthcare supplements. CBD oil products account for approximately 52% of recent product innovations because liquid formulations provide superior dosage flexibility and absorption efficiency for dogs and cats. Organic pet wellness formulations experienced approximately 31% growth because companion animal owners increasingly demand clean-label and plant-based healthcare products.

CBD jelly products improving pet administration acceptance by approximately 24% are increasingly integrated into flavored calming and relaxation supplements. Veterinary-approved CBD wellness formulations contribute nearly 26% of advanced product development because pet healthcare professionals increasingly support anxiety and sleep-support applications. Pet anxiety products represent approximately 37% of innovation demand because behavioral wellness management remains the dominant application category globally.

Five Recent Developments (2023-2025)

1. In 2023, Curaleaf expanded veterinary-supported pet CBD oil production, improving distribution coverage by approximately 22% across companion animal healthcare retail networks.
2. In 2024, Pet Releaf launched organic CBD pet treats that improved administration acceptance by nearly 24% among anxiety-management product users.
3. In 2025, Diamond CBD introduced THC-free pet wellness capsules with dosage accuracy improvements of approximately 21% for sleep-support applications.
4. In 2024, Bluebird Botanicals upgraded organic hemp extraction technologies, improving cannabinoid purity levels by approximately 18% across pet wellness products.
5. In 2023, Canna-Pet expanded online pet healthcare subscriptions, increasing recurring customer engagement by approximately 19% across digital wellness platforms.

Report Coverage of Pet CBD (cannabidiol) Market

The Pet CBD (cannabidiol) Market Report provides detailed analysis of hemp-derived companion animal wellness products across pet anxiety, gastrointestinal disorders, sleep-support, and general pet healthcare applications. The report evaluates global pet wellness adoption exceeding approximately 66%, while natural supplement preference contributes nearly 41% of companion animal healthcare purchasing activities worldwide. It includes segmentation by type, where CBD oil products dominate with approximately 52% market share, CBD capsules contribute nearly 21%, CBD jelly products account for approximately 18%, and other formulations represent around 9% of total utilization.

The Pet CBD (cannabidiol) Industry Report analyzes application trends where pet anxiety contributes approximately 37% of total market demand, gastrointestinal disease treatments account for nearly 24%, sleep disorder applications represent approximately 19%, and other wellness applications contribute around 20% of utilization. Online retail channels account for approximately 48% of product distribution because digital pet healthcare purchasing and subscription-based wellness services continue expanding rapidly.